DaVita Inc. (NYSE: DVA) is a medical company that provides kidney dialysis services for patients with chronic kidney failure or end-stage renal disease (ESRD). The company operates kidney dialysis centres alongside outpatient, hospital inpatient, and home-based hemodialysis services. It also offers disease management services, vascular access services, clinical research programs, physician services, and comprehensive care services.
DVA DaVita Inc NYSE
97.48 USD -2.60% -2.60
OPEN 99.33
PREV CLOSE 100.08
DAY RANGE 100.00 - 97.48
VOLUME 422.7K
AVG. VOLUME 522K
52 WEEK RANGE 103.00 - 65.28
Buy DVA stocks now with Interactive Brokers – the most advanced investment platform
Valuations metrics
Market capitalization 8.8B
Enterprise value 21.7B
Trailing pe 18.186567
Forward pe 13.501386
Peg ratio 13.501386
Price to sales ttm 0.75794315
Price to book mrq 10.70503
Enterprise to revenue 1.864
Enterprise to ebitda 10.742
Financials
Fiscal year ends 2022-12-31
Most recent quarter 2023-03-31
Profit margin 0.04405
Operating margin 0.110249996
Return on assets ttm 0.04754
Return on equity ttm 0.30372
Income statement
Revenue ttm 11.7B
Revenue per share ttm 127.444
Quarterly revenue growth 0.02
Gross profit ttm 3.4B
Ebitda 2B
Net income to common ttm 500.4M
Diluted eps ttm 5.36
Quarterly earnings growth yoy -0.287
Balance sheet
Total cash mrq 367.1M
Total cash per share mrq 4.047
Total debt mrq 11.5B
Total debt to equity mrq 475.853
Current ratio mrq 1.185
Book value per share mrq 9.106
Cash flow
Operating cash flow ttm 1.7B
Levered free cash flow ttm 0.9B
Stock statistics
Shares outstanding 90.7M
Float shares 53.7M
Avg 10 volume 522K
Avg 30 volume 709.3K
Shares short 2.8M
Short ratio 3.93
Short percent of shares outstanding 0.052600004
Percent held by insiders 0.03225
Percent held by institutions 0.88629997
Stock price summary
Fifty two week low 65.28
Fifty two week high 103
Fifty two week change 7.971
Beta 0.93596
Day 50 ma 90.8638
Day 200 ma 83.2234
Dividends and splits
Last split factor 2-for-1 split
Last split date 2013-09-09